Hepatocellular carcinoma (HCC) is one of the main cancer-related causes of death
worldwide. Thus, there is a constant search for improvement in screening, diagnosis, and …

There is great geographical variation in the distribution of hepatocellular carcinoma (HCC),
with the majority of all cases worldwide found in the Asia–Pacific region, where HCC is one …

Hepatocellular carcinoma (HCC) is the most common primary liver cancer and has been
acknowledged as a leading cause of death among cirrhosis patients. Difficulties in early …

Hepatocellular carcinoma is the most common type of malignant tumour in Asia. Treatment
is decided according to the staging system with information on tumour burden and liver …

The shortage of donor livers considered suitable for transplantation has driven the
development of novel methods for organ preservation and reconditioning. Machine …

Expansion of the liver transplantation indication criteria for patients with hepatocellular
carcinoma (HCC) has long been debated. Here we propose new, expanded living‐donor …

Background and aims Human telomerase reverse transcriptase (hTERT) plays an important
role in cancer invasion, but the relevant mechanism is not well known. This study aims to …

Hepatocellular carcinoma (HCC) is one of most prevalent cancer and is a serious healthcare
issue worldwide. Portal vein tumor thrombus (PVTT) is a frequent complication and remains …

Liver transplantation (LT) is the only effective method of treating end‐stage liver disease,
such as various types of liver failure. China has the largest number of patients with hepatitis …

The liver is endowed with an amazing regenerative capacity that allows it to withstand an
enormous amount of damage. Nevertheless, it is precisely this highly regenerative capacity …